PsyBio Therapeutics Corp. (PSYBF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 50 Thousand | 62.5 Thousand | 1.53 Million | - | - | - |
| Gross Profit | -50 Thousand | -62.5 Thousand | -1.53 Million | - | - | - |
| Operating Expenses | 4.4 Million | 9.6 Million | 4.9 Million | 38.96 Thousand | 20.86 Thousand | 39.85 Thousand |
| Selling, General and Administrative Expenses | 3.94 Million | 8.89 Million | 4.84 Million | 38.96 Thousand | 20.86 Thousand | 39.85 Thousand |
| Research and Development Expenses | 390.13 Thousand | 622.79 Thousand | 54.54 Thousand | - | - | - |
| Other Expenses | 28.11 Thousand | 89.64 Thousand | - | - | - | - |
| Cost and Expenses | 4.55 Million | 9.66 Million | 6.43 Million | 38.96 Thousand | 20.86 Thousand | 39.85 Thousand |
| Operating Income | -4.55 Million | -8.22 Million | -6.43 Million | -38.97 Thousand | -20.86 Thousand | -39.84 Thousand |
| Interest Expense | 21.05 Thousand | - | - | - | - | - |
| Income Tax Expense | - | 1.43 Million | 0.35 | -171.86 Thousand | -161.14 Thousand | - |
| Earnings before Tax | -4.88 Million | -11.01 Million | -6.43 Million | -16.15 Thousand | -20.86 Thousand | -39.85 Thousand |
| Net Income | -4.88 Million | -11.01 Million | -6.43 Million | -16.15 Thousand | -20.86 Thousand | -39.85 Thousand |
| Earnings Per Share Basic | -0.04 | -0.10 | -0.20 | - | -0.01 | -0.02 |
| Earnings Per Share Diluted | -0.04 | -0.10 | -0.20 | - | -0.01 | -0.02 |
| Weighted Average Shares Outstanding | 111.81 Million | 106.93 Million | 31.59 Million | - | 2.35 Million | 2.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 111.81 Million | 106.93 Million | 31.59 Million | - | 2.35 Million | 2.33 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -4.52 Million | - | - | -16.15 Thousand | -20.86 Thousand | -39.84 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 25 Thousand | 12.5 Thousand | 38.07 Thousand | 50 Thousand | 12.5 Thousand | 25 Thousand |
| Gross Profit | -25 Thousand | -12.5 Thousand | -38.07 Thousand | -50 Thousand | -12.5 Thousand | -25 Thousand |
| Operating Expenses | 131.99 Thousand | 788.97 Thousand | 947.15 Thousand | 4.7 Million | 912.5 Thousand | 1.36 Million |
| Selling, General and Administrative Expenses | 105.08 Thousand | 717.18 Thousand | 720.24 Thousand | - | 845.3 Thousand | 1.14 Million |
| Research and Development Expenses | - | - | 151.94 Thousand | - | 2947.00 | 131.04 Thousand |
| Other Expenses | 26.9 Thousand | - | 1.00 | 28.11 Thousand | 2522.00 | 14.47 Thousand |
| Cost and Expenses | 156.99 Thousand | 801.47 Thousand | 947.15 Thousand | 4.75 Million | 925 Thousand | 1.39 Million |
| Operating Income | -156.99 Thousand | -801.47 Thousand | -947.15 Thousand | -4.72 Million | -922.48 Thousand | -1.38 Million |
| Interest Expense | - | 3392.00 | 4432.00 | 21.05 Thousand | 5429.00 | 6399.00 |
| Income Tax Expense | -19.01 | 3392.00 | 4433.00 | 49.16 Thousand | 7951.00 | 20.87 Thousand |
| Earnings before Tax | -181.99 Thousand | -811.49 Thousand | -941.64 Thousand | -4.88 Million | -921.89 Thousand | -1.43 Million |
| Net Income | -181.99 Thousand | -811.49 Thousand | -941.64 Thousand | -4.88 Million | -921.89 Thousand | -1.43 Million |
| Earnings Per Share Basic | -0.00 | -0.01 | -0.02 | - | -0.01 | -0.01 |
| Earnings Per Share Diluted | -0.00 | -0.01 | -0.02 | - | -0.01 | -0.01 |
| Weighted Average Shares Outstanding | 128.17 Million | 128.17 Million | 62.7 Million | 111.81 Million | 111.33 Million | 111.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 128.17 Million | 128.17 Million | 62.7 Million | 111.81 Million | 111.33 Million | 111.89 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -156.99 Thousand | -763.45 Thousand | -909.13 Thousand | - | -884.46 Thousand | -1.34 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
DVYSR
1798
3630
NCLIND
ALTX
AVCRF